Tenax Therapeutics (TENX) Common Equity (2011 - 2026)
Tenax Therapeutics (TENX) posted quarterly Common Equity of $113.6 million for Q2 2026, up 9.93% year-over-year from $103.3 million in Q2 2025, and down 0.96% on a QoQ basis from $114.7 million in Q1 2026.
Tenax Therapeutics (TENX) Common Equity (2011 - 2026) Analysis & Trends
Tenax Therapeutics has reported Common Equity for 16 years, with the latest figure at $113.6 million in Q2 2026.
- Common Equity for Q2 2026 came in at $113.6 million, up 9.93% year-over-year; the trailing twelve-month figure through Jun 2026 was $113.6 million (up 9.93% YoY), and the FY2025 annual result was $97.1 million, up 5.52% from the prior year.
- Common Equity eased to $113.6 million in Q2 2026, from $114.7 million in the prior quarter.
- Over five years, Common Equity peaked at $114.7 million in Q1 2026 and troughed at $1.5 million in Q4 2022.
- A 5-year average of $50.3 million and a median of $13.7 million in 2023 frame the typical range for Common Equity.
- The widest annual swing landed in 2022, when Common Equity slumped 64.83%; it then jumped 1064.15% in 2025.
- A 5-year view of Common Equity shows it stood at $1.5 million in 2022, then soared by 442.4% to $8.1 million in 2023, then soared by 1036.0% to $92.0 million in 2024, then grew by 5.52% to $97.1 million in 2025, then rose by 17.02% to $113.6 million in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $113.6 million in Q2 2026, $114.7 million in Q1 2026, and $97.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.79 Bn |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - | 113.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 113.59 Mn |
| Mar 31, 2026 | 114.69 Mn |
| Dec 31, 2025 | 97.07 Mn |
| Sep 30, 2025 | 96.21 Mn |
| Jun 30, 2025 | 103.33 Mn |
| Mar 31, 2025 | 109.29 Mn |
| Dec 31, 2024 | 91.99 Mn |
| Sep 30, 2024 | 97.22 Mn |
| Jun 30, 2024 | 8.88 Mn |
| Mar 31, 2024 | 12.43 Mn |
| Dec 31, 2023 | 8.10 Mn |
| Sep 30, 2023 | 11.29 Mn |
| Jun 30, 2023 | 13.22 Mn |
| Mar 31, 2023 | 14.28 Mn |
| Dec 31, 2022 | 1.49 Mn |
| Sep 30, 2022 | 3.95 Mn |
| Jun 30, 2022 | 6.78 Mn |
| Mar 31, 2022 | 1.61 Mn |
| Dec 31, 2021 | 4.24 Mn |
| Sep 30, 2021 | 7.24 Mn |